The anti-inflammatory and anti-apoptotic effects of IL-6 deficiency observed in the WTI model and the BLM model during the early phase using IL6−/− mice differs from the pro-apoptotic effects of pharmacological inhibition of IL-6 in the acute BLM model using an IL-6 neutralizing antibody. This evidence concerns the gene IL6 and Bloom syndrome.